Join the Atopic Dermatitis group to help and get support from people like you.
Atopic Dermatitis News
Related terms: Atopic Eczema, Dermatitis, Atopic, Discoid Eczema, Infantile Eczema
FDA Approves Zoryve for Atopic Dermatitis
THURSDAY, July 11, 2024 – The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric...
FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in i...
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
TUESDAY, June 18, 2024 – Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study...
High-Salt Diets Might Raise Eczema Risk
WEDNESDAY, June 5, 2024 – Doctors already warn folks off salt due to its heart risks, but new research suggests sodium isn't helping your skin either. Researchers found that as daily salt intake...
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis
TUESDAY, May 28, 2024 – Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA...
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk
WEDNESDAY, May 8, 2024 – Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published...
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...
Atopic Dermatitis Negatively Impacts Mental Health
TUESDAY, April 23, 2024 – Atopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 i...
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 – Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study...
Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
TUESDAY, March 12, 2024 – Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with ...
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
FRIDAY, March 8, 2024 – There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published...
Climatic Hazards Linked to Aggravation of Atopic Dermatitis
WEDNESDAY, Jan. 24, 2024 – Climatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in...
Dupixent (dupilumab) U.S. Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement
TARRYTOWN, N.Y. and PARIS, Jan. 16, 2024 (GLOBE NEWSWIRE) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has updated the...
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires
WEDNESDAY, Jan. 3, 2024 – An increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
prednisone, methylprednisolone, clobetasol, fluocinonide, Dupixent, dexamethasone, desonide, halobetasol